Norepinephrine Bitartrate Injection 4mg per 250 mL in 0.9% Sodium Chloride, 4 mg, 250 mL excel ba...

FDA Recall #D-0706-2022 — Class II — March 14, 2022

Recall #D-0706-2022 Date: March 14, 2022 Classification: Class II Status: Terminated

Product Description

Norepinephrine Bitartrate Injection 4mg per 250 mL in 0.9% Sodium Chloride, 4 mg, 250 mL excel bag, Rx only, Athenex Pharma Solutions, LLC, Clarence, NY, 14031, NDC 76154-474-15

Reason for Recall

Defective container

Recalling Firm

Athenex Pharma Solutions, LLC — Clarence, NY

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

4,270 bags

Distribution

USA nationwide.

Code Information

Lot #: F2101628, F2101629, F2101630, F2101631, Exp 4/28/22; F2101632, F2101633, Exp 4/29/22; F2101795, F2101796, Exp 5/27/22

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated